Influenza as an issue on the agenda of different stakeholders A multidisciplinary point of viewOSTERHAUS, A. D. M. E.Vaccine. 2006, Vol 24, Num 44-46, pp 6796-6799, issn 0264-410X, 4 p.Article

Research on cell hybridization in the NetherlandsOSTERHAUS, A. D. M. E.Progress in industrial microbiology. 1984, Vol 20, pp 237-244, issn 0079-6352Article

Pandemic preparedness : Different perspectives How ready are we for the next pandemic?OSTERHAUS, A. D. M. E.Vaccine. 2006, Vol 24, Num 44-46, pp 6800-6806, issn 0264-410X, 7 p.Article

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012MEIJER, A; JONGES, M; BEEK, P. Van et al.Euro surveillance. 2012, Num DEC, pp 154-160, issn 1025-496X, 7 p., NSArticle

Influenza Vaccination Is Efficacious and Safe in Renal Transplant RecipientsSCHARPE, J; EVENEPOEL, P; MAES, B et al.American journal of transplantation (Print). 2008, Vol 8, Num 2, pp 332-337, issn 1600-6135, 6 p.Article

Misconceptions concerning influenza : An overview and clear answersMONTO, A; OSTERHAUS, A. D. M. E.Vaccine. 2006, Vol 24, Num 44-46, pp 6779-6782, issn 0264-410X, 4 p.Article

Cytotoxic T lymphocyte memory : role in cross-protective immunity against influenza ?RIMMELZWAAN, G. F; OSTERHAUS, A. D. M. E.Vaccine. 1995, Vol 13, Num 8, pp 703-705, issn 0264-410XArticle

The control of influenza : antivirals as an adjunct to vaccinesOSTERHAUS, A. D. M. E; DE JONG, J. C.Vaccine. 1999, Vol 18, Num 9-10, pp 779-780, issn 0264-410XArticle

Vaccination against acute respiratory virus infections and measles in manOSTERHAUS, A. D. M. E; DE VRIES, P.Immunobiology (1979). 1992, Vol 184, Num 2-3, pp 180-192, issn 0171-2985Article

Detection of a novel human coronavirus by real-time reverse -transcription polymerase chain reactionCORMAN, V. M; ECKERLE, I; MUTH, D et al.Euro surveillance. 2013, Num JUL, pp 30-35, issn 1025-496X, 6 p., NS2Article

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infectionsCORMAN, V. M; MÜLLER, M. A; BLEICKER, T et al.Euro surveillance. 2013, Num JUL, pp 36-44, issn 1025-496X, 9 p., NS2Article

An unusual cause of a usual presentationGOEIJENBIER, M; NUR, E; GORIS, M et al.Netherlands journal of medicine. 2011, Vol 69, Num 6, issn 0300-2977, 285, 289 [2 p.]Article

Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodiesSCHUTTEN, M; MCKNIGHT, A; HUISMAN, R. C et al.AIDS (London). 1993, Vol 7, Num 7, pp 919-923, issn 0269-9370Article

Fifty years of influenza surveillance: a challenge for the 21st century, Geneva, 17-19 February, 1999KITLER, M. E; LAVANCHY, D; OSTERHAUS, A. D. M. E et al.Vaccine. Supplement. 2002, Vol 20, issn 1359-5938, 93 p., 2Conference Proceedings

Selective inhibitory effects of (5)-9-(3-hydroxy-2-phosphonyl-methoxypropyl) adenine and 1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)-5-iodouracil on seal herpesvirus (Phocid herpesvirus 1) infection in vitroOSTERHAUS, A. D. M. E; GROEN, J; DE CLERQ, E et al.Antiviral research. 1987, Vol 7, Num 4, pp 221-226, issn 0166-3542Article

Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibodyUYTDEHAAG, F. G. C. M; OSTERHAUS, A. D. M. E.The Journal of immunology (1950). 1985, Vol 134, Num 2, pp 1225-1229, issn 0022-1767Article

Pathogenesis of RSV lower respiratory tract infection : implications for vaccine developmentBRANDENBURG, A. H; NEIJENS, H. J; OSTERHAUS, A. D. M. E et al.Vaccine. 2001, Vol 19, Num 20-22, pp 2769-2782, issn 0264-410XArticle

Evaluation of two commercially available immunoassays for the detection of hantavirus antibodies in serum samplesKORAKA, P; AVSIC-ZUPANC, T; OSTERHAUS, A. D. M. E et al.Journal of clinical virology. 2000, Vol 17, Num 3, pp 189-196, issn 1386-6532Article

IgM antibodies in hospitalized children with febrile illness during an inter-epidemic period of measles, in SomaliaNUR, Y. A; GROEN, J; YUSUF, M. A et al.Journal of clinical virology. 1999, Vol 12, Num 1, pp 21-25, issn 1386-6532Article

Towards an HIV-1 vaccine : lessons from studies in macaque modelsHULSKOTTE, E. G. J; GERETTI, A.-M; OSTERHAUS, A. D. M. E et al.Vaccine. 1998, Vol 16, Num 9-10, pp 904-915, issn 0264-410XArticle

A case of human rabies in The NetherlandsGROEN, J; VEERING, M. M; LEENTVAAR-KUIPERS, A et al.Infection. 1998, Vol 26, Num 3, issn 0300-8126, p. 196Article

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitroRIMMELZWAAN, G. F; BAARS, M; CLAAS, E. C. J et al.Journal of virological methods. 1998, Vol 74, Num 1, pp 57-66, issn 0166-0934Article

Hantavirus nephropathy in the Netherlands : clinical, histopathological and epidemiological findingsGERDING, M. N; GROEN, J; JORDANS, J. G. M et al.Netherlands journal of medicine. 1995, Vol 47, Num 3, pp 106-112, issn 0300-2977Conference Paper

Risk of infections transmitted by arthropods and rodents in forestry workersMOLL VAN CHARANTE, A. W; GROEN, J; OSTERHAUS, A. D. M. E et al.European journal of epidemiology. 1994, Vol 10, Num 3, pp 349-351, issn 0393-2990Conference Paper

Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formationANDEWEG, A. C; LEEFLANG, P; OSTERHAUS, A. D. M. E et al.Journal of virology. 1993, Vol 67, Num 6, pp 3232-3239, issn 0022-538XArticle